Join us for the Auxilium-MBI Venture Showcase, where founders from our Healthcare Accelerator will present their companies and connect with investors, mentors and members of the startup community.
Wednesday, September 23rd, 2026
5:00 PM – 7:30 PM
Auxilium Worcester, 3rd Floor,
311 Main St, Worcester, MA
The Auxilium-MBI Venture Showcase marks the conclusion of the inaugural Auxilium-MBI Healthcare & Life Sciences Accelerator, a three-month program supporting early-stage companies as they work to build and scale their businesses.
Join us to hear pitches from the four companies in our first cohort, meet the founders behind them and learn more about the technologies they are building and the progress they have made throughout the program.
CPR Therapeutics Inc. is developing a next-generation technology for cardiopulmonary resuscitation. Supported by the NIH and NSF, the Company has developed a multimodal wrap-around type of CPR that is more effective and safer than current solutions. These devices improve blood flow, enhance the effectiveness of electrical countershock, and reduce the risk of CPR-related injury. They will be the first non-invasive automated devices to improve survival from sudden cardiac arrest.
Microvitality is developing the first non-invasive small intestine sampling tool, enabling accurate, accessible diagnostics for conditions like SIBO, IBS, and Celiac Disease. Developed by Tufts engineers and pre-seed backed, the Boston-based startup is advancing toward first-in-human clinical validation to transform how GI conditions are diagnosed and managed.
Predictive Healthcare is delivering AI-powered postoperative monitoring through its MyHealthPal™ platform. The FDA-listed solution helps clinicians remotely track recovery, identify patients at elevated risk of complications, and intervene earlier. MyHealthPal also provides patients with a curated library of procedure-specific education and recovery guidance before and after surgery, improving engagement and adherence throughout the care journey. The platform is being deployed across health systems and surgical programs to improve outcomes while reducing the cost of care.
SilkMed is a Massachusetts-based MedTech company transforming burn care with a patented, sprayable silk fibroin hydrogel dressing. Developed from Tufts-originated science, their platform is biocompatible, shelf-stable and fully conformal, delivering regenerative performance and controlled therapeutic delivery for complex wounds while fitting real-world clinical and reimbursement needs.
